期刊
TRANSLATIONAL STROKE RESEARCH
卷 7, 期 5, 页码 378-387出版社
SPRINGER
DOI: 10.1007/s12975-016-0482-6
关键词
Administration routes; Stem cell therapy; Stroke; Translational research
资金
- Research Institute Carlos III, Spanish Ministry of Science and Innovation and European Regional Development Fund [PS12/01754, INVICTUS (RD12/0014/0006)]
Cell-based therapy has demonstrated safety and efficacy in experimental animal models of stroke, as well as safety in stroke patients. However, various questions remain regarding the therapeutic window, dosage, route of administration, and the most appropriate cell type and source, as well as mechanisms of action and immune-modulation to optimize treatment based on stem cell therapy. Various delivery routes have been used in experimental stroke models, including intracerebral, intraventricular, subarachnoid, intra-arterial, intraperitoneal, intravenous, and intranasal routes. From a clinical point of view, it is necessary to demonstrate which is the most feasible, safest, and most effective for use with stroke patients. Therefore, further experimental studies concerning the safety, efficacy, and mechanisms of action involved in these therapeutic effects are required to determine their optimal clinical use.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据